poland the pharma market m. ruzikowski. poland - the pharma market agenda: industry market...
TRANSCRIPT
Poland
The Pharma Market
M. Ruzikowski
Poland - The Pharma Market
Agenda:
Industry
Market
International relation
Polish pharmaceutical industry
Source: Ministry of Economy of Poland
Description 2005 2006 2007
Total incomes in millions € 3 045,14 3 360,73 3 590,71
Total costs in millions € 2 662,95 2 969,88 3 234,80
Gros profitability in % 12,60 11,60 9,90
Net profitability in % 10,30 9,70 8,60
Import to Poland in millions € 2 172,03 2 554,00 3 173,99
Export from Poland in millions € 366,32 474,91 746,54
Polish pharmaceutical industry
Economic results [1]
3,05
3,36
3,59
2,66
2,97
3,23
2,00
2,20
2,40
2,60
2,80
3,00
3,20
3,40
3,60
3,80
2005 2006 2007
Va
lue
s i
n b
illio
ns
€
Total incomes Total costsSource: Ministry of Economy of Poland
Economic results [2]
12,6011,60
9,9010,309,70
8,60
0,00
2,00
4,00
6,00
8,00
10,00
12,00
14,00
2005 2006 2007
%
Gros profitability Net profitability
Polish pharmaceutical industry
Source: Ministry of Economy of Poland
Economic results [3]
2,17
2,55
3,17
0,37 0,470,75
0,00
0,50
1,00
1,50
2,00
2,50
3,00
3,50
2005 2006 2007
Va
lue
in
bil
lio
ns
€
Import to Poland Export from Poland
Polish pharmaceutical industry
6,00%
7,00%
8,00%
9,00%
10,00%
11,00%
12,00%
Germany France Portugal Slovenia UnitedKingdom
Spain CzechRepublic
Bulgaria Poland Romania
Pharmaceutical market in Poland
Source: EGA, Eurostat
%GDP assigned to the healthcare
Pharmaceutical market in Poland
Reimbursement of the Rx medicines through the State in Euros per person
125119
10897
92
73
57
41 38 35
0
20
40
60
80
100
120
140
Slovenia CzechRepublic
Hungary Slovakia Cyprus Malta Estonia Lithuania Poland Latvia
Source: EGA, Eurostat
Pharmaceutical market in Poland
32,99
21,06
18,95
12,35
3,441,90 1,61
0,98 0,56 0,35
0,00
5,00
10,00
15,00
20,00
25,00
30,00
35,00
Germany France UnitedKingdom
Spain Poland CzechRepublic
Portugal Romania Bulgaria Slovenia
Market of the generic medicines in billion €
Source: EGA Information
Pharmaceutical market in Poland
Source: EGA information
Valuable participation of the generic medicines in the pharmaceutical market
50,0%
39,4%35,6%
30,0% 30,0%
21,0% 20,0%
13,4% 13,0%
5,3%
0,0%
10,0%
20,0%
30,0%
40,0%
50,0%
60,0%
Slovenia Poland Germany Romania Bulgaria UnitedKingdom
CzechRepublic
France Portugal Spain
Pharmaceutical market in Poland
Value of the sale in € million
2 560 2 593 2 807 2 935 3 154 2 935 3 154
869 921 993 1 049 1 212 1 049 1 212
250 261 292 323 373 323 373
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2003 2004 2005 2006 2007 MAT/12/2006 MAT/12/2007
Rx medicines OTC Medicines Others
66%
26%
8%
Source: IMS data
Pharmaceutical market in PolandOTC vs. Rx medicines valuable participation
74,70% 73,80% 73,90% 73,70% 72,70% 73,70% 72,20%
25,30% 26,20% 26,10% 26,30% 27,80% 26,30% 27,80%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2003 2004 2005 2006 2007 MAT/12/2006 MAT/12/2007
Rx Medicines OTC Medicines
Source: IMS data
Pharmaceutical market in Poland
Source: IMS data
OTC vs. Rx medicines quantitative participation
48,50% 48,70% 48,90% 49,80% 49,60% 49,80% 49,60%
51,50% 51,30% 51,10% 50,20% 50,40% 50,20% 50,40%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2003 2004 2005 2006 2007 MAT/12/2006 MAT/12/2007
Rx Medicines OTC Medicines
• Pharmacy market of the Rx products 2006 vs. 1999 = 1,5 bln €
• Top ten from market of the civilization diseases grow up - 58%
• Next ten diseases from market grow up - 8%
• Other disease from our market grow up – 34%
Pharmaceutical market in Poland
Pos. ATC code Description
Antihypertensives
Drugs used in diabetes
Drugs for obstructive airway diseases
Anti-infectives for systemic use
Lipid modyfing agents
Drugs for acid related disorders
Psycholeptics
Anthithrombotic agent
Analgesic
Urologicals
11 Others
1 C02
2 A10B
4 J
5
3 R03
6
7
8
9
C10
A02
N05
B01
10
N02
G04
Source: IMS data
Pharmaceutical market in Poland
Pharmacy market of the Rx products 12/2006 – 12/2007
Therapeutic classes have got the growth
Source: IMS data
45,745,3
41,6
35,9
32,7
29,7
28,1
27,2
26,320,2
524,5
C09C - Angiotensin II antagonist, plain
R03DA - Other systemic drugs for obstructiveairway diseases
C09AA - ACE inhibitors,plain
C07A - Beta blocking agent
G03A - Hormonal contraceptives for systemicuse
B01C - Antithrombotic agents
R03D - Leukotriene receptor antagonist
J01F - Macrolides, lincosamides andstreprogramis
A08A - Antiobesity preparation
S01A - Antiglaucoma preparation and miotics
Others
Polish pharmaceutical market
Source: IMS & PharmaExpert data
Description 2005 2006 2007 2008
Value of the pharmacy market in billions € (gross)
5,47 5,90 6,25 6,53
Value of the hospital market in billions € (net)
xx 0,54 0,56 xx
Value of the medical devices market in billions €
1,17 1,31 xx xx
Medical devices market in Poland
207,17
297,42
328,78
0,00
50,00
100,00
150,00
200,00
250,00
300,00
350,00
Val
ue
in m
illio
n €
2003 2004 2005
Total incomes
Source: Polmed PL
Medical devices market in Poland
198,41
244,51
297,47
0,00
50,00
100,00
150,00
200,00
250,00
300,00
Val
ue
in m
illio
n €
2003 2004 2005
Export from Poland
Source: Polmed PL
592,24687,47
815,52
0,00
100,00
200,00
300,00
400,00
500,00
600,00
700,00
800,00
900,00
Val
ue
in m
illio
n €
2003 2004 2005
Import to Poland
Medical devices market in Poland
Source: Polmed PL
